January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Antabio SAS
Antabio is a privately held clinical stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to WHO critical priority pathogens.